Associated Papers
Clinical Characteristics and Molecular Genetic Analysis of a Pedigree with Glanzmann's Thrombasthenia.
Zhu Q et al.
Alternative Therapies in Health and Medicine, 2024
Profiling the Genetic and Molecular Characteristics of Glanzmann Thrombasthenia: Can It Guide Current and Future Therapies?
Nurden A
Journal of Blood Medicine, 2021
Two homozygous missense mutations in ITGB3 gene as a cause of Glanzmann Thrombasthenia in four consanguineous Pakistani pedigrees.
Ali T et al.
International Journal of Laboratory Hematology, 2020
Identification of one novel pathogenic ITGB3 mutation and two known mutations in two Chinese pedigrees with hereditary Glanzmann thrombasthenia.
Lu Z et al.
Platelets, 2020
Acquired Antibodies to αIIbβ3 in Glanzmann Thrombasthenia: From Transfusion and Pregnancy to Bone Marrow Transplants and Beyond.
Nurden AT
Transfusion Medicine Reviews, 2018
Congenital platelet disorders and understanding of platelet function.
Nurden AT et al.
British Journal of Haematology, 2014
Glanzmann thrombasthenia: state of the art and future directions.
Nurden AT et al.
Seminars in Thrombosis and Hemostasis, 2013
Demonstration of novel gain-of-function mutations of αIIbβ3: association with macrothrombocytopenia and glanzmann thrombasthenia-like phenotype.
Kashiwagi H et al.
Molecular Genetics & Genomic Medicine, 2013
C560Rβ3 caused platelet integrin αII b β3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality.
Fang J et al.
Journal of Thrombosis and Haemostasis : Jth, 2013
Molecular dynamics analysis of a novel β3 Pro189Ser mutation in a patient with glanzmann thrombasthenia differentially affecting αIIbβ3 and αvβ3 expression.
Laguerre M et al.
Plos One, 2013
Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.
Nurden AT et al.
Expert Review of Hematology, 2012
Advances in our understanding of the molecular basis of disorders of platelet function.
Nurden A et al.
Journal of Thrombosis and Haemostasis : Jth, 2011
Heterozygous ITGA2B R995W mutation inducing constitutive activation of the αIIbβ3 receptor affects proplatelet formation and causes congenital macrothrombocytopenia.
Kunishima S et al.
Blood, 2011
Glanzmann thrombasthenia: an update.
Franchini M et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry, 2010
Select a paper to view details